China Universal Asset Management Co., Ltd. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$44
-24.1%
2,739
+96.8%
0.01%
-27.8%
Q2 2023$58
-32.6%
1,392
-2.6%
0.02%
-37.9%
Q1 2023$86
+10.3%
1,429
+34.1%
0.03%
-6.5%
Q4 2022$78
-99.9%
1,066
+8.7%
0.03%
-3.1%
Q3 2022$75,0009810.03%
Other shareholders
NOVOCURE LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders